UPCOMING DEADLINE REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Athenex, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm | National News

THE ANGEL, April 16, 2021 / PRNewswire / – Schall law firm, a national shareholder law firm, is reminding investors of a class action lawsuit against Athenex, Inc. (“Athenex” or “the Company”) (NASDAQ: ATNX) for violating Sections 10 (b) and 20 (a) des Securities Exchange Act of 1934 and rule 10b-5 published by the US Securities and Exchange Commission.

Investors who have bought the Company’s securities between 7th August 2019 and February 26, 2021inclusive (the “Lesson Period”) it is recommended to contact the Company beforehand May 32021.

If you are a shareholder who has suffered a loss, click here to participate.

We also encourage you to get in touch Brian Schall the law firm Schall, 2049 Century Park East, Suite 2460, Los Angeles, California 90067, 310-301-3335 to discuss your rights free of charge. You can also contact us on the company’s website at www.schallfirm.com or by email at brian@schallfirm.com.

In this case, the class has not yet been certified and you will not be represented by a lawyer until certification. If you don’t take action, you can remain an absent class member.

According to the complaint, the company made false and misleading statements to the market. Athenex announced March 1, 2021announced that the FDA issued a full response letter (“CRL”) to the Company’s New Drug Application (“NDA”) for oral paclitaxel plus encequidar for the treatment of metastatic breast cancer. The FDA’s CRL identified the risks and uncertainties in patient safety associated with the results of the primary endpoint for Objective Response Rate (“ORR”) that may have biased the blinded clinical review. The FDA recommended that the company conduct “a new adequate and well-performed clinical trial in a patient population with metastatic breast cancer representative of the US population.” The FDA also stated that the toxicity would require a risk reduction strategy for treatment to be approved. Based on the news, Athenex shares fell 55% in one day.

Join the case to make up for your losses.

Schall law firm represents investors around the world and specializes in class action and shareholder disputes.

This press release may be viewed as a solicitor’s advertisement in some jurisdictions under applicable laws and ethical rules.

CONTACT:

The law firm Schall

Brian Schall, Esq.,

www.schallfirm.com

Office: 310-301-3335

info@schallfirm.com

To download multimedia, view the original content at: http://www.prnewswire.com/news-releases/upcoming-deadline-reminder-the-schall-law-firm-reminds-investors-of-a-class-action -lawsuit-against-athenex-inc-and-encourages-investors-with-losses-over-100-000- to-contact-the-company-301270701.html

SOURCE The law firm Schall

Comments are closed.